Skip to main content
Erschienen in: Diabetologia 8/2010

01.08.2010 | Article

Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction—a nationwide study

verfasst von: M. L. Norgaard, S. S. Andersen, T. K. Schramm, F. Folke, C. H. Jørgensen, M. L. Hansen, C. Andersson, D. M. Bretler, A. Vaag, L. Køber, C. Torp-Pedersen, G. H. Gislason

Erschienen in: Diabetologia | Ausgabe 8/2010

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

We assessed secular trends of cardiovascular outcomes following first diagnosis of myocardial infarction (MI) or diabetes in an unselected population.

Methods

All Danish residents aged ≥30 years without prior diabetes or MI were identified by individual-level linkage of nationwide registers. Individuals hospitalised with MI or claiming a first-time prescription for a glucose-lowering medication (GLM) during the period from 1997 to 2006 were included. Analyses were by Poisson regression models. Primary endpoints were death by all causes, cardiovascular death and MI.

Results

The study included 3,092,580 individuals, of whom 77,147 had incident MI and 118,247 new-onset diabetes. MI patients had an increased short-term risk of all endpoints compared with the general population. The rate ratio (RR) for cardiovascular death within the first year after MI was 11.1 (95% CI 10.8–11.5) in men and 14.8 (14.3–15.3) in women, respectively. The risk rapidly declined and 1 year after the index MI, RR was 2.11 (2.00–2.23) and 2.8 (2.64–2.97) in men and women, respectively. Patients with diabetes carried a constantly elevated risk of all endpoints compared with the general population. The cardiovascular death RR was 1.90 (1.77–2.04) and 1.92 (1.78–2.07) in men and women, respectively during the first year after GLM initiation.

Conclusions/interpretation

Incident MI is associated with high short-term risk, which decreases rapidly over time. Incident diabetes is associated with a persistent excessive cardiovascular risk after initiation of GLM therapy. This further strengthens the necessity of early multi-factorial intervention in diabetes patients for long-term benefit.
Literatur
1.
Zurück zum Zitat Schramm TK, Gislason GH, Kober L et al (2008) Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 117:1945–1954CrossRefPubMed Schramm TK, Gislason GH, Kober L et al (2008) Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 117:1945–1954CrossRefPubMed
2.
Zurück zum Zitat Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234CrossRefPubMed Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234CrossRefPubMed
3.
Zurück zum Zitat Dale AC, Vatten LJ, Nilsen TI, Midthjell K, Wiseth R (2008) Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study. BMJ 337:a236CrossRefPubMed Dale AC, Vatten LJ, Nilsen TI, Midthjell K, Wiseth R (2008) Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study. BMJ 337:a236CrossRefPubMed
4.
Zurück zum Zitat Booth GL, Kapral MK, Fung K, Tu JV (2006) Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368:29–36CrossRefPubMed Booth GL, Kapral MK, Fung K, Tu JV (2006) Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368:29–36CrossRefPubMed
5.
Zurück zum Zitat Preis SR, Hwang SJ, Coady S et al (2009) Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 119:1728–1735CrossRefPubMed Preis SR, Hwang SJ, Coady S et al (2009) Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 119:1728–1735CrossRefPubMed
6.
Zurück zum Zitat Thomas RJ, Palumbo PJ, Melton LJ 3rd et al (2003) Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970–1994. Arch Intern Med 163:445–451CrossRefPubMed Thomas RJ, Palumbo PJ, Melton LJ 3rd et al (2003) Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970–1994. Arch Intern Med 163:445–451CrossRefPubMed
8.
Zurück zum Zitat Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46:263–268PubMed Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46:263–268PubMed
9.
Zurück zum Zitat Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M (2003) The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 56:124–130CrossRefPubMed Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M (2003) The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 56:124–130CrossRefPubMed
10.
Zurück zum Zitat Andersen HR, Nielsen TT, Rasmussen K et al (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349:733–742CrossRefPubMed Andersen HR, Nielsen TT, Rasmussen K et al (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349:733–742CrossRefPubMed
11.
Zurück zum Zitat Gislason GH, Abildstrom SZ, Rasmussen JN et al (2005) Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995–2002. Scand Cardiovasc J 39:42–49CrossRefPubMed Gislason GH, Abildstrom SZ, Rasmussen JN et al (2005) Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995–2002. Scand Cardiovasc J 39:42–49CrossRefPubMed
12.
Zurück zum Zitat Rasmussen JN, Gislason GH, Abildstrom SZ et al (2005) Statin use after acute myocardial infarction: a nationwide study in Denmark. Br J Clin Pharmacol 60:150–158CrossRefPubMed Rasmussen JN, Gislason GH, Abildstrom SZ et al (2005) Statin use after acute myocardial infarction: a nationwide study in Denmark. Br J Clin Pharmacol 60:150–158CrossRefPubMed
13.
Zurück zum Zitat Kontny F (2001) Improving outcomes in acute coronary syndromes—the FRISC II trial. Clin Cardiol 24:I3–I7CrossRefPubMed Kontny F (2001) Improving outcomes in acute coronary syndromes—the FRISC II trial. Clin Cardiol 24:I3–I7CrossRefPubMed
14.
Zurück zum Zitat Fox KA, Mehta SR, Peters R et al (2004) Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events (CURE) Trial. Circulation 110:1202–1208CrossRefPubMed Fox KA, Mehta SR, Peters R et al (2004) Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events (CURE) Trial. Circulation 110:1202–1208CrossRefPubMed
15.
Zurück zum Zitat Gislason GH, Rasmussen JN, Abildstrom SZ et al (2006) Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J 27:1153–1158CrossRefPubMed Gislason GH, Rasmussen JN, Abildstrom SZ et al (2006) Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J 27:1153–1158CrossRefPubMed
16.
Zurück zum Zitat Lee HY, Cooke CE, Robertson TA (2008) Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. J Manag Care Pharm 14:271–280PubMed Lee HY, Cooke CE, Robertson TA (2008) Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. J Manag Care Pharm 14:271–280PubMed
17.
Zurück zum Zitat Malacrida R, Genoni M, Maggioni AP et al (1998) A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group. New Engl J Med 338:8–14CrossRefPubMed Malacrida R, Genoni M, Maggioni AP et al (1998) A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group. New Engl J Med 338:8–14CrossRefPubMed
18.
Zurück zum Zitat Dominguez H, Schramm TK, Norgaard ML et al (2009) Initiation and persistence to statin treatment in patients with diabetes receiving glucose-lowering medications 1997–2006. Open Cardiovasc Med J 3:152–159CrossRefPubMed Dominguez H, Schramm TK, Norgaard ML et al (2009) Initiation and persistence to statin treatment in patients with diabetes receiving glucose-lowering medications 1997–2006. Open Cardiovasc Med J 3:152–159CrossRefPubMed
19.
Zurück zum Zitat Turner RC, Cull CA, Frighi V, Holman RR (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281:2005–2012CrossRefPubMed Turner RC, Cull CA, Frighi V, Holman RR (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281:2005–2012CrossRefPubMed
20.
Zurück zum Zitat Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589CrossRefPubMed Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589CrossRefPubMed
21.
Zurück zum Zitat Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393CrossRefPubMed Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393CrossRefPubMed
22.
Zurück zum Zitat Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591CrossRefPubMed Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591CrossRefPubMed
23.
Zurück zum Zitat Gerstein HC, Miller ME, Byington RP et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559CrossRefPubMed Gerstein HC, Miller ME, Byington RP et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559CrossRefPubMed
24.
Zurück zum Zitat Duckworth W, Abraira C, Moritz T et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129–139CrossRefPubMed Duckworth W, Abraira C, Moritz T et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129–139CrossRefPubMed
25.
Zurück zum Zitat Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572CrossRefPubMed Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572CrossRefPubMed
26.
Zurück zum Zitat Krarup LH, Boysen G, Janjua H, Prescott E, Truelsen T (2007) Validity of stroke diagnoses in a National Register of Patients. Neuroepidemiology 28:150–154CrossRefPubMed Krarup LH, Boysen G, Janjua H, Prescott E, Truelsen T (2007) Validity of stroke diagnoses in a National Register of Patients. Neuroepidemiology 28:150–154CrossRefPubMed
27.
Zurück zum Zitat Gaist D, Sorensen HT, Hallas J (1997) The Danish prescription registries. Dan Med Bull 44:445–448PubMed Gaist D, Sorensen HT, Hallas J (1997) The Danish prescription registries. Dan Med Bull 44:445–448PubMed
28.
Zurück zum Zitat Fox CS, Sullivan L, D'Agostino RB Sr, Wilson PW (2004) The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diab Care 27:704–708CrossRef Fox CS, Sullivan L, D'Agostino RB Sr, Wilson PW (2004) The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diab Care 27:704–708CrossRef
29.
Zurück zum Zitat Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diab Care 15:815–819CrossRef Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diab Care 15:815–819CrossRef
30.
Zurück zum Zitat Howard BV, Best LG, Galloway JM et al (2006) Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diab Care 29:391–397CrossRef Howard BV, Best LG, Galloway JM et al (2006) Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diab Care 29:391–397CrossRef
31.
Zurück zum Zitat Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A (2006) Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 47:65–71CrossRefPubMed Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A (2006) Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 47:65–71CrossRefPubMed
32.
Zurück zum Zitat Labarere J, Stone RA, Obrosky DS et al (2007) Comparison of outcomes for low-risk outpatients and inpatients with pneumonia: a propensity-adjusted analysis. Chest 131:480–488CrossRefPubMed Labarere J, Stone RA, Obrosky DS et al (2007) Comparison of outcomes for low-risk outpatients and inpatients with pneumonia: a propensity-adjusted analysis. Chest 131:480–488CrossRefPubMed
33.
Zurück zum Zitat American Diabetes Association (2008) Economic costs of diabetes in the U.S. in 2007. Diabetes Care 31:596–615CrossRef American Diabetes Association (2008) Economic costs of diabetes in the U.S. in 2007. Diabetes Care 31:596–615CrossRef
34.
Zurück zum Zitat Abildstrom SZ, Rasmussen S, Madsen M (2005) Changes in hospitalization rate and mortality after acute myocardial infarction in Denmark after diagnostic criteria and methods changed. Eur Heart J 26:990–995CrossRefPubMed Abildstrom SZ, Rasmussen S, Madsen M (2005) Changes in hospitalization rate and mortality after acute myocardial infarction in Denmark after diagnostic criteria and methods changed. Eur Heart J 26:990–995CrossRefPubMed
Metadaten
Titel
Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction—a nationwide study
verfasst von
M. L. Norgaard
S. S. Andersen
T. K. Schramm
F. Folke
C. H. Jørgensen
M. L. Hansen
C. Andersson
D. M. Bretler
A. Vaag
L. Køber
C. Torp-Pedersen
G. H. Gislason
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 8/2010
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1783-z

Weitere Artikel der Ausgabe 8/2010

Diabetologia 8/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.